Med_vir

2021 miRNA-223 as a regulator of inflammation and NLRP3 inflammasome, the main fragments in the puzzle of immunopathogenesis of different inflammatory diseases and COVID-19

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481106/

Латенция (латентная вирусная инфекция)

Virus Latency

The ability of a pathogenic virus to lie dormant within a cell (LATENT INFECTION).

Year introduced: 1994

2021 Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706188/

2021 Stress-Induced Epstein-Barr Virus Reactivation
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470332/

2021 Modulation of host cell signaling during cytomegalovirus latency and reactivation
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524946/

2021 Recent Issues in Varicella-Zoster Virus Latency
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540691/

2021 Latency Reversing Agents: Kick and Kill of HTLV-1?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197370/

2021 Potential Effects of Human Papillomavirus Type Substitution, Superinfection Exclusion and Latency on the Efficacy of the Current L1 Prophylactic Vaccine

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823767/

Новые подходы к терапии ВИЧ/СПИД

2021 SMAC Mimetics as Therapeutic Agents in HIV Infection
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660680/

2021 New Latency Reversing Agents for HIV-1 Cure: Insights from Nonhuman Primate Models
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402914/

2021 Are BET Inhibitors yet Promising Latency-Reversing Agents for HIV-1 Reactivation in AIDS Therapy?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228869/

2021 Combinatorial Use of Both Epigenetic and Non-Epigenetic Mechanisms to Efficiently Reactivate HIV Latency
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036438/

HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926981/

2021 Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883034/

The biological and clinical significance of emerging SARS-CoV-2 variants

Covid-19- Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear

Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses- SARS-CoV, MERS-CoV, and SARS-CoV-2

Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors

Type I Interferons in COVID-19 Pathogenesis

SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses

Host Immune Response to Influenza A Virus Infection

Prions prionoids and protein misfolding disorders.

Innate immune evasion by picornaviruses.

Pathogenicity and virulence of Japanese encephalitis virus- Neuroinflammation and neuronal cell damage.

Zika Virus Pathogenesis- A Battle for Immune Evasion.

The Molecular Interactions of ZIKV and DENV with the Type-I IFN Response.